Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation

Conditions : Rectal Cancer Patients Interventions : Drug: Long-course concurrent chemoradiotherapy combined with Adebrelimab and Apatinib Sponsors : Harbin Medical University Active, not recruiting